SynthesisPloS one2022

The efficacy and tolerability of combining pemetrexed-based chemotherapy with gefitinib in the first-line treatment of non-small cell lung cancer with mutated EGFR: A pooled analysis of randomized clinical trials.

Bi-Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.